We are live on ! Find out more
GI

GS Investments Portfolio holdings

AUM $175M
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+19.38%
3 Year Est. Return
+77.6%
5 Year Est. Return
+105.02%
10 Year Est. Return
AUM
$121M
AUM Growth
-$15.8M
Cap. Flow
-$1.11M
Cap. Flow %
-0.92%
Top 10 Hldgs %
37.88%
Holding
130
New
12
Increased
36
Reduced
44
Closed
15

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$1.3M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.15M
3
HSIC icon
Henry Schein
HSIC
+$1.06M
4
PRLB icon
Protolabs
PRLB
+$915K
5
TXN icon
Texas Instruments
TXN
+$872K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$2.09M
2
STZ icon
Constellation Brands
STZ
+$1.14M
3
UNH icon
UnitedHealth
UNH
+$1.06M
4
RVLV icon
Revolve Group
RVLV
+$636K
5
PYPL icon
PayPal
PYPL
+$509K

Sector Composition

Rank Sector Weight
1 Healthcare 17.06%
2 Technology 16.62%
3 Financials 14.19%
4 Industrials 12.39%
5 Consumer Discretionary 11.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLB icon
1
Protolabs
PRLB
$1.79B
$8.94M 7.4%
75,130
+9,235
+14% +$915K
TXN icon
2
Texas Instruments
TXN
$255B
$6.93M 5.74%
62,821
+7,069
+13% +$872K
AAPL icon
3
Apple
AAPL
$4.9T
$5.09M 4.21%
109,940
+2,664
+2% +$171K
WFC icon
4
Wells Fargo
WFC
$258B
$4.01M 3.32%
72,285
-790
-1% -$41.4K
META icon
5
Meta Platforms (Facebook)
META
$1.37T
$3.81M 3.16%
19,617
-460
-2% -$89.1K
HD icon
6
Home Depot
HD
$332B
$3.73M 3.09%
19,122
-563
-3% -$128K
TMO icon
7
Thermo Fisher Scientific
TMO
$214B
$3.69M 3.06%
17,837
-65
-0.4% -$19.7K
DIS icon
8
Walt Disney
DIS
$167B
$3.37M 2.79%
32,120
-455
-1% -$63.5K
V icon
9
Visa
V
$673B
$3.25M 2.69%
24,565
-2,770
-10% -$499K
SYK icon
10
Stryker
SYK
$133B
$2.92M 2.42%
17,316
-272
-2% -$56.5K
BKNG icon
11
Booking.com
BKNG
$150B
$2.83M 2.34%
34,875
-25
-0.1% -$1.96K
CTSH icon
12
Cognizant
CTSH
$24.3B
$2.65M 2.19%
33,525
+10,565
+46% +$653K
NKTR icon
13
Nektar Therapeutics
NKTR
$2.41B
$2.63M 2.18%
3,593
-20
-0.6% -$5.8K
ROST icon
14
Ross Stores
ROST
$81B
$2.54M 2.1%
29,960
+865
+3% +$97.3K
SCHW
15
Charles Schwab
SCHW
$181B
$2.52M 2.09%
49,265
-1,740
-3% -$76.7K
AMP icon
16
Ameriprise Financial
AMP
$48.1B
$2.5M 2.07%
17,845
+1,030
+6% +$160K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$4.08T
$2.35M 1.94%
41,560
-1,380
-3% -$89K
ECL icon
18
Ecolab
ECL
$78.6B
$2.29M 1.9%
16,315
-300
-2% -$56.9K
MSFT icon
19
Microsoft
MSFT
$3.35T
$2.28M 1.89%
23,080
-1,635
-7% -$240K
BA icon
20
Boeing
BA
$175B
$2.25M 1.86%
6,700
+108
+2% +$38.2K
AMZN icon
21
Amazon
AMZN
$2.53T
$2.24M 1.86%
26,360
-5,060
-16% -$448K
INCY icon
22
Incyte
INCY
$24.9B
$2.2M 1.82%
32,825
AMGN icon
23
Amgen
AMGN
$209B
$2.2M 1.82%
11,892
-411
-3% -$90.6K
HSIC icon
24
Henry Schein
HSIC
$9.7B
$1.92M 1.59%
26,409
+16,055
+155% +$1.06M
HON icon
25
Honeywell
HON
$76.7B
$1.86M 1.54%
13,682
+229
+2% +$37.4K

Similar funds

GS Investments's Q4 2019 Portfolio in Review

As of Q4 2019, GS Investments held 130 positions worth $121M, down 12% from $137M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

GS Investments's Q4 2019 filing shows 12 new, 36 increased, 44 reduced and 15 closed positions. Its largest new stake was McKesson: 9,200 shares worth $1.23M. The largest sale was Celgene Corp, an estimated $2.09M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • GS Investments's largest Q4 2019 buy was McKesson: 9,200 shares worth $1.23M.
  • GS Investments added most to Henry Schein in Q4 2019, an estimated $1.06M increase.
  • GS Investments's biggest Q4 2019 reduction was UnitedHealth, cutting an estimated $1.06M.
  • GS Investments fully exited Celgene Corp in Q4 2019, selling an estimated $2.09M.
  • GS Investments's ten largest holdings make up 38% of its $121M portfolio in Q4 2019.
  • GS Investments opened 12 new positions and closed 15 in Q4 2019.
  • GS Investments's portfolio value fell 12% quarter-over-quarter to $121M.

Based on GS Investments's 13F filing for Q4 2019, filed 4 Feb 2020.